Today, there was an article on WallStreetJournal.com – New Views on Hormone Therapy in Menopause This is the kind of press we need about women’s hormones! Women have to understand that they CAN safely choose hormones because there is a safety difference between the different types of hormones and routes of delivery. They’ve also got … Continued
wall street journal
According to industry analysts and reported in the Wall Street Journal Today, the number of insured Americans using medical services has declined significantly, as a result of a dwindling economy. While previous recessions have impacted the utilization of medical services in the past, experts say that the downward trend we’re faced with today appears to be more widespread. Harsh economic times have cornered many Americans into opting for insurance policies with higher deductibles. As a result, insurance claims, physician visits and hospital admissions have all steadily declined since 2009…
As a gynecologist working primarily in the field of hormone replacement for the past 8 years, saliva testing is an integral part of how I treat my patients. In my OB/GYN residency, I was taught to prescribe as Dr. Utian says: start with low doses and increase according to symptoms. Well, it just plain doesn’t work to do it that way. Without testing patients’ hormone levels, it is impossible to determine if a patient’s symptoms of hair loss are from low estrogen, high cortisol or low thyroid. All 3 hormonal imbalances can lead to the same set of symptoms.
Wyeth has a big presence in hormone replacement therapy, selling drugs women use to treat the symptoms of menopause. Sales of Wyeth’s hormone replacement drugs, Premarin and Prempro, reached nearly $2 billion in 2001. The field took a big hit in 2002, when a large federal study found that women who took certain hormones had a higher risk of breast cancer, heart disease and stroke.
Dr. Alicia Stanton, Chief Medical Officer, BodyLogicMD of Manchester applauds Drs. Schwartz, Holtorf and Brownstein for clearing some of the confusion surrounding bioidentical hormone replacement therapy. Dr. Stanton shares her thoughts on the Wall Street Journal article published yesterday.
“The medical establishment must stop kowtowing to drug companies and start serving women’s best interests — and that involves widely prescribing bioidentical hormones. This will lead to healthier, happier women and, in the long run, help reduce America’s skyrocketing health-care costs.”